Regeneron Pharmaceuticals (REGN)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 373 |
| % of all portfolios: | 0.018% |
| Hold Price * : | $960.70 |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q1 2023 | |||||
| ≡ | Thomas Gayner - Markel Asset Management | Sell 100.00% | 30,500 | 0.30 | |
| Q4 2022 | |||||
| ≡ | Thomas Gayner - Markel Asset Management | Reduce 62.02% | 49,800 | 0.49 | |
| Q2 2022 | |||||
| ≡ | Bill Nygren - Oakmark Select Fund | Sell 100.00% | 224,000 | 3.18 | |
| ≡ | Polen Capital Management | Sell 100.00% | 1,383 | 0.00 | |
| Q1 2022 | |||||
| ≡ | Bill Nygren - Oakmark Select Fund | Reduce 22.76% | 66,000 | 0.94 | |
| ≡ | Polen Capital Management | Reduce 28.64% | 555 | 0.00 | |
| Q4 2021 | |||||
| ≡ | Polen Capital Management | Reduce 10.07% | 217 | 0.00 | |
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 490 | 0.00 | |
| Q3 2021 | |||||
| ≡ | Bill Nygren - Oakmark Select Fund | Reduce 6.45% | 20,000 | 0.24 | |
| Q1 2021 | |||||
| ≡ | Polen Capital Management | Sell 100.00% | 2,002,804 | 2.25 | |
| Q4 2020 | |||||
| ≡ | Bill Nygren - Oakmark Select Fund | Reduce 83.92% | 104,400 | 1.25 | |
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 588 | 0.01 | |
| Q3 2020 | |||||
| ≡ | Bill Nygren - Oakmark Select Fund | Reduce 59.08% | 179,600 | 3.03 | |
| Q2 2020 | |||||
| ≡ | Bill Nygren - Oakmark Select Fund | Reduce 19.79% | 75,000 | 1.34 | |
| Q1 2020 | |||||
| ≡ | Bill Nygren - Oakmark Select Fund | Reduce 38.87% | 241,000 | 3.89 | |
| Q2 2019 | |||||
| ≡ | Polen Capital Management | Reduce 1.09% | 17,448 | 0.03 | |
| Q1 2019 | |||||
| ≡ | Bill Nygren - Oakmark Select Fund | Reduce 9.47% | 45,000 | 0.41 | |
| Q4 2018 | |||||
| ≡ | Bill Nygren - Oakmark Select Fund | Reduce 20.83% | 125,000 | 1.13 | |
| Q3 2011 | |||||
| ≡ | Dodge & Cox | Sell 100.00% | 145,128 | 0.02 | |
| Q1 2011 | |||||
| ≡ | Seth Klarman - Baupost Group | Sell 100.00% | 1,000,000 | 1.96 | |
| Q2 2009 | |||||
| ≡ | Bill & Melinda Gates Foundation Trust | Sell 100.00% | 35,500 | 0.01 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.